Advanced in Facial Ectodermal Dysplasia

Franck Boralevi

Place Amélie Raba Léon, 
Bordeaux, FR 
Advanced in Facial Ectodermal Dysplasia
Place Amélie Raba Léon, 
Bordeaux, FR 
OverviewLocationsClinical Research

Overview

Franck Boralevi practices in Bordeaux, France. Mr. Boralevi is rated as an Advanced expert by MediFind in the treatment of Facial Ectodermal Dysplasia. His top areas of expertise are Keratosis Pilaris, Erosive Pustular Dermatosis of the Scalp, Atopic Dermatitis, and Scabies.

His clinical research consists of co-authoring 109 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Facial Ectodermal Dysplasia.

Gender
Male

Locations

Place Amélie Raba Léon, Bordeaux, 33000, France
Other Locations
CHU Lyon
Lyon, France
AP HP, CHU Henri Mondor
Creteil, France
Talence, France
Pessac-sur-dordogne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
Enrollment Status: Terminated
Publish Date: March 25, 2022
Intervention Type: Other
Study Phase: Not Applicable
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

109 Total Publications

Management of scabies in children under 15 kg and pregnant or breastfeeding women: recommendations supported by the Centre of Evidence of the French Society of Dermatology.
Management of scabies in children under 15 kg and pregnant or breastfeeding women: recommendations supported by the Centre of Evidence of the French Society of Dermatology.
Journal: The British journal of dermatology
Published: February 17, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Boralevi's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 49 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile